Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies Disponible en: https://t.co/pzGMmOfuU3
RT @LauraLorenteF: Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Re…
Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies | SpringerLink https://t.co/ZMWspWTojC
虚血性脳卒中のリスクへの影響はダビガトラン、リバーロキサバン、アピキサバンで同様であるが、アピキサバンは他の2剤と比較して大出血のリスク低下と関連した。 https://t.co/dRLsfWAciE
RT @AntoniosDouros: With higher quality #RWE piling up, it seems that while #DOAC are equally effective in stroke prevention in AF, #apixab…
Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation:- PubMed - NCBI https://t.co/pVSNHO2DS4 Validity of a metaanalysis of observational studies ?
RT @AntoniosDouros: With higher quality #RWE piling up, it seems that while #DOAC are equally effective in stroke prevention in AF, #apixab…
RT @CheloXPtw: Anticoagulantes orales de acción directa en FA: metaanálisis de estudios observacionales en Drug Safety. AVC isquémico: ries…
With higher quality #RWE piling up, it seems that while #DOAC are equally effective in stroke prevention in AF, #apixaban is associated with a lower risk of bleeding compared with #dabigatran or #rivaroxaban. Check out our new paper in @DrugSafetyJ https:/
RT @CheloXPtw: Anticoagulantes orales de acción directa en FA: metaanálisis de estudios observacionales en Drug Safety. AVC isquémico: ries…
RT @CheloXPtw: Anticoagulantes orales de acción directa en FA: metaanálisis de estudios observacionales en Drug Safety. AVC isquémico: ries…
RT @CheloXPtw: Anticoagulantes orales de acción directa en FA: metaanálisis de estudios observacionales en Drug Safety. AVC isquémico: ries…
Anticoagulantes orales de acción directa en FA: metaanálisis de estudios observacionales en Drug Safety. AVC isquémico: riesgo similar. Hemorragia mayor: rivaroxabán >riesgo que dabigatrán; apixabán <riesgo que dabigatrán y rivaroxabán https://t.co/n
RT @PersonalizeAF: #AFib Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systema…
#AFib Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies. https://t.co/8hGZMvXuZd